Samuel T Haile

Title: Innovations by Samuel T. Haile

Introduction

Samuel T. Haile is a notable inventor based in Castro Valley, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CARs) for cancer treatment. With a total of 2 patents, his work is paving the way for advancements in targeted therapies.

Latest Patents

Haile's latest patents include innovative designs for chimeric antigen receptors. One of his patents focuses on CARs that comprise an NGK2D ecto domain, which are essential for developing compositions, cells, and cell therapies. Additionally, he has worked on prostate cancer chimeric antigen receptors that include antibodies and T cell receptors with anti-PMCA antigen binding domains. His research also encompasses SynNotch receptors that feature an anti-PSCA binding domain, further enhancing the potential for effective cancer treatments.

Career Highlights

Samuel T. Haile is currently associated with Kite Pharma, Inc., a leading company in the field of cell therapy. His work at Kite Pharma has allowed him to collaborate with other talented professionals in the industry, contributing to groundbreaking advancements in cancer therapies.

Collaborations

Some of his notable coworkers include Kevin P. Meng and Jodi Murakami. Their combined expertise fosters an environment of innovation and progress in the development of new therapeutic approaches.

Conclusion

Samuel T. Haile's contributions to the field of biotechnology through his patents and work at Kite Pharma, Inc. highlight his role as a key innovator in cancer treatment. His ongoing research and collaborations continue to inspire advancements in medical science.